|
Re: Zenith and Pfizer collaboration news
|
3
|
Resverlogix Corp.
|
Nov 20, 2018 10:12AM
|
|
Re: Apabetalone downregulates factors and pathways associated with vascular calcification
|
3
|
Resverlogix Corp.
|
Nov 20, 2018 10:53AM
|
|
Re: Happy Thanksgiving to all our American friends
|
6
|
Resverlogix Corp.
|
Nov 22, 2018 10:36AM
|
|
Re: Mace Events Study / Type 2 Diabetes / Control Arms 26 CVOT Trials
|
4
|
Resverlogix Corp.
|
Nov 29, 2018 11:24AM
|
|
Re: Mace Events Study / Type 2 Diabetes / Control Arms 26 CVOT Trials
|
2
|
Resverlogix Corp.
|
Nov 29, 2018 01:31PM
|
|
Re: Did another Seeking Alpha Instablog post...
|
3
|
Resverlogix Corp.
|
Dec 03, 2018 11:12AM
|
|
Are statins overprescribed? Why the risks and benefits are so complex
|
3
|
Resverlogix Corp.
|
Dec 04, 2018 10:17AM
|
|
Re: The runway is clear....
|
1
|
Resverlogix Corp.
|
Dec 06, 2018 07:05AM
|
|
Re: No love
|
2
|
Resverlogix Corp.
|
Dec 13, 2018 12:31PM
|
|
Re: No love
|
3
|
Resverlogix Corp.
|
Dec 13, 2018 12:39PM
|
|
Re: No love
|
3
|
Resverlogix Corp.
|
Dec 13, 2018 12:59PM
|
|
Re: Two Thoughts - 250 and 270
|
2
|
Resverlogix Corp.
|
Dec 14, 2018 05:26AM
|
|
Re: Tick tock
|
3
|
Resverlogix Corp.
|
Dec 15, 2018 07:59AM
|
|
8th positive safety review out this morning
|
2
|
Resverlogix Corp.
|
Dec 19, 2018 08:54AM
|
|
Re: Difference between DSMB #7 and DSMB #8
|
1
|
Resverlogix Corp.
|
Dec 19, 2018 04:24PM
|
|
Is this important,..
|
2
|
Resverlogix Corp.
|
Dec 19, 2018 05:21PM
|
|
Re: Coronary Artery Calcium Score
|
4
|
Resverlogix Corp.
|
Dec 21, 2018 11:20AM
|
|
Re: Holding steady
|
3
|
Resverlogix Corp.
|
Dec 22, 2018 02:44PM
|
|
We held up well again today,..
|
3
|
Resverlogix Corp.
|
Dec 24, 2018 12:59PM
|
|
Re: NASH is a $35 Billion US/year market
|
2
|
Resverlogix Corp.
|
Dec 31, 2018 09:49AM
|
